Relypsa Reports the Presentation of its Two-Part Pivotal Phase 3 Patiromer …

Relypsa Reports the Presentation of its Two-Part Pivotal Phase 3 Patiromer …
Part B, the placebo controlled randomized withdrawal part of the trial, was designed to provide additional evidence of the efficacy of patiromer in treating hyperkalemia and to assess the need for chronic dosing. Subjects from Part A whose baseline … Read more on EON: Enhanced Online News (press release)

Are Benzodiazepines and Antidepressants Making Us Sicker?
It works very quickly to calm anxiety, but the clinical trials demonstrate (and most people can attest) that these benefits are pretty much gone by 4-6 weeks.10 But the withdrawal symptoms were so horrific and in many cases so lingering11 that in 1975 … Read more on Tucson Citizen

The Narconon Vista Bay Treatment Guarantee – The majority of people who complete the Narconon Vista Bay drug and alcohol rehab program are able to overcome their dependency on the substances with one st…